Physician specialty
Surgical Oncology
At a glance
- Practicing in the U.S.
- 1,920
- Per 100,000 residents
- 0.6
- Women
- 43%
- Median years since graduating
- 20
Training path
- College (bachelor’s degree) 4 years
- Medical school (MD or DO) 4 years
- General surgery residency 5 years
- Complex general surgical oncology fellowship 2 years
Training after medical school: 7 years. From the start of college: about 15 years.
Usual minimum program lengths from ACGME program requirements. Some doctors take extra research years or a second fellowship.
Who they are
- MD (DOs make up the rest) 96%
- Women 43%
- Graduated 35 or more years ago 15%
- Offer telehealth 42%
- Accept Medicare’s approved amount 97%
Sex and credentials from NPPES. Graduation year, telehealth and Medicare assignment from Medicare Care Compare, which covers clinicians enrolled in Medicare.
Where they practice
What they do most for Medicare patients
- Established patient office or other outpatient visit, 20-29 minutes 61,128
- Established patient office or other outpatient visit, 30-39 minutes 49,398
- New patient office or other outpatient visit, 60-74 minutes 27,542
- New patient office or other outpatient visit, 45-59 minutes 20,573
- Established patient office or other outpatient visit, 40-54 minutes 20,240
- Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 11,512
- Partial removal of breast 11,372
- Established patient office or other outpatient visit, 10-19 minutes 10,638
- Biopsy or removal of deep lymph nodes of underarm 8,681
- Imaging of lymph nodes during surgery 8,637
- New patient office or other outpatient visit, 30-44 minutes 5,932
- Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes 5,169
Services billed to traditional Medicare in 2023 (Physician and Other Practitioners data); drugs given in the office are left out.
What they prescribe most
- Tramadol Hcl 12.8%
- Hydrocodone/Acetaminophen (Hydrocodone-Acetaminophen) 11.4%
- Oxycodone Hcl (Oxycontin, Roxicodone, Roxybond) 9.3%
- Lipase/Protease/Amylase (Zenpep, Creon, Pancreaze) 5.7%
- Pantoprazole Sodium (Protonix Iv, Protonix) 4.9%
- Anastrozole (Arimidex) 4.8%
- Levothyroxine Sodium (Euthyrox, Levo-T, Ermeza) 4.5%
- Oxycodone Hcl/Acetaminophen (Endocet, Oxycodone-Acetaminophen, Percocet) 3.8%
- Cephalexin 2.9%
- Gabapentin (Gralise, Neurontin) 2.4%
- Metronidazole (Noritate, Nuvessa, Vandazole) 2.4%
- Neomycin Sulfate 1.7%
- Tamoxifen Citrate (Soltamox) 1.7%
- Acetaminophen With Codeine (Acetaminophen-Codeine) 1.7%
- Ondansetron 1.5%
Share of this specialty’s Medicare Part D prescriptions in 2024, including refills. Select a drug to see which of these clinicians prescribe it most, and where.
Hospitals where the most work
- Cedars-Sinai Medical Center Los Angeles, CA 18 Surgical Oncology at Cedars-Sinai Medical Center
- Vanderbilt University Medical Center Nashville, TN 18 Surgical Oncology at Vanderbilt University Medical Center
- Mount Sinai Hospital New York, NY 16 Surgical Oncology at Mount Sinai Hospital
- Ut of Texas Southwestern University Hospital - William P. Clements Jr. Dallas, TX 15 Surgical Oncology at Ut of Texas Southwestern University Hospital - William P. Clements Jr.
- NYU Langone Hospitals New York, NY 15 Surgical Oncology at NYU Langone Hospitals
- Banner Thunderbird Medical Center Glendale, AZ 14 Surgical Oncology at Banner Thunderbird Medical Center
- UPMC Presbyterian Shadyside Pittsburgh, PA 14 Surgical Oncology at UPMC Presbyterian Shadyside
- Brigham and Women's Hospital Boston, MA 14 Surgical Oncology at Brigham and Women's Hospital
- University of Alabama Hospital Birmingham, AL 13 Surgical Oncology at University of Alabama Hospital
- Banner Gateway Medical Center Gilbert, AZ 13 Surgical Oncology at Banner Gateway Medical Center
Clinicians who list the hospital in Medicare Care Compare. The number opens the list of who works there.
Schools they graduated from most
- University of Michigan Medical School 27
- New York University School of Medicine 24
- Columbia University College of Physicians and Surgeons 19
- Georgetown University School of Medicine 19
- Johns Hopkins University School of Medicine 19
- University of Maryland School of Medicine 18
- University of Cincinnati College of Medicine 17
- Boston University School of Medicine 16
- Duke University School of Medicine 16
- Indiana University School of Medicine 16
From Medicare Care Compare (Medicare-enrolled clinicians only).
Industry payments
Drug and device makers reported $3.5M in general payments to 1,125 clinicians in Surgical Oncology in 2025. See who received the most
Source: CMS Open Payments, program year 2025. A payment is not evidence of wrongdoing.
Research in this field
U.S. researchers published 53,546 articles and reviews in oncology in 2024–2026.
Journals with the most U.S. papers
- Journal of Clinical Oncology Lippincott Williams & Wilkins 2,249
- Cancers Multidisciplinary Digital Publishing Institute 1,010
- Annals of Oncology Elsevier BV 978
- Cureus Cureus, Inc. 902
- Annals of Surgical Oncology Springer Science+Business Media 863
- Gynecologic Oncology Elsevier BV 737
- International Journal of Radiation Oncology*Biology*Physics Elsevier BV 673
- Laboratory Investigation Elsevier BV 652
- Neuro-Oncology Oxford University Press 615
- Transplantation and Cellular Therapy Elsevier BV 615
Most-cited recent papers
- Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (opens in a new tab) CA A Cancer Journal for Clinicians, 2024 · cited 30,549 times · free to read
- Cancer statistics, 2024 (opens in a new tab) CA A Cancer Journal for Clinicians, 2024 · cited 10,142 times · free to read
- Cancer statistics, 2025 (opens in a new tab) CA A Cancer Journal for Clinicians, 2025 · cited 3,609 times · free to read
- Global patterns and trends in breast cancer incidence and mortality across 185 countries (opens in a new tab) Nature Medicine, 2025 · cited 1,408 times
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study (opens in a new tab) The Lancet, 2024 · cited 974 times
- Breast cancer statistics 2024 (opens in a new tab) CA A Cancer Journal for Clinicians, 2024 · cited 905 times · free to read
- The Lancet Commission on prostate cancer: planning for the surge in cases (opens in a new tab) The Lancet, 2024 · cited 827 times · free to read
- Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma (opens in a new tab) New England Journal of Medicine, 2024 · cited 683 times · free to read
From OpenAlex, an open index of research papers. Papers with at least one author at a U.S. institution, classified by subject; the subject covers the whole field, so related specialties share these lists. Citation counts change daily.
Sources: CMS NPPES (counts, sex, credentials), Medicare Care Compare (schools, graduation years, hospitals, telehealth), CMS Medicare Physician & Other Practitioners (2023) and Part D Prescribers (2024), CMS Open Payments (2025), ACGME program requirements (training length), OpenAlex (research), U.S. Census Bureau ACS 2020–2024 (population).